![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Guihard Soizic Peyrouze Pauline Cheok Meyling H
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.13, Iss.15, 2012-11, pp. : 1759-1772
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The clinically relevant pharmacogenomic changes in acute myelogenous leukemia
Pharmacogenomics, Vol. 13, Iss. 11, 2012-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenomic considerations for immunosuppressive therapy
Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. :